XML 53 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segment Information (Tables)
 12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Information concerning combined operations by business segment
Information concerning operations of our business segment is presented in the following table (in millions):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Net Sales
 
 
 
 
 
Medical Devices
$
611.6

 
$
566.2

 
$
509.0

Corporate and Other
—

 
—

 
—

Total Net Sales
611.6

 
566.2

 
509.0

Operating Profit (Loss)
 
 
 
 
 
Medical Devices
155.2

 
123.8

 
107.8

Corporate and Other(a)(b)(c)
(178.2
)
 
(211.2
)
 
(227.3
)
Other (expense) income, net(d)
(20.1
)
 
(19.7
)
 
(16.2
)
Total Operating Loss
(43.1
)
 
(107.1
)
 
(135.7
)
Interest income
2.5

 
0.6

 
0.3

Interest expense
(31.6
)
 
(32.7
)
 
(33.1
)
Loss before Income Taxes
$
(72.2
)
 
$
(139.2
)
 
$
(168.5
)
_______________________________________________
(a)
For the year ended December 31, 2017, Corporate and other costs included $116 million, respectively, of costs historically presented as a component of the S&IP business, $55 million of general expenses, $5 million of restructuring costs and $8 million of acquisition-related charges partially offset by a $6 million benefit related to realignment of internal policies for our post-divestiture business.
(b)
For the year ended December 31, 2016, Corporate and other costs included $114 million of costs historically presented as a component of the S&IP business, $66 million of general expenses, $14 million of post spin-related costs $18 million, respectively, of acquisition-related charges.
(c)
For the year ended December 31, 2015, Corporate and other costs included $133 million of costs historically presented as a component of the S&IP business, $49 million of general expenses and $46 million of post spin-related expenses.
(d)
Other expense, net is primarily costs related to litigation and legal matters.
Depreciation, amortization and capital expenditures by segment
Depreciation, amortization and capital expenditures are as follows (in millions):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Depreciation and Amortization
 
 
 
 
 
Medical Devices
$
27.4

 
$
30.4

 
$
30.8

Corporate and Other(a)
32.1

 
34.8

 
34.6

Total Depreciation and Amortization
59.5

 
65.2

 
65.4

 
 
 
 
 
 
Capital Expenditures
 
 
 
 
 
Medical Devices
$
21.9

 
$
17.7

 
$
23.2

Corporate and Other(b)
21.3

 
11.4

 
47.2

Total Capital Expenditures
$
43.2

 
$
29.1

 
$
70.4

_______________________________________________
(a)
Depreciation and Amortization in Corporate and Other includes depreciation of corporate assets and depreciation and amortization of assets associated with discontinued operations (See “Discontinued Operations” in Note 2).
(b)
Corporate and other capital expenditures includes expenditures for corporate assets and expenditures associated with discontinued operations.
Information concerning assets by business segment
Information concerning assets by business segment is presented in the following table (in millions):
 
As of December 31,
 
2017
 
2016
Assets
 
 
 
Medical Devices
$
1,189.6

 
$
1,197.2

Corporate and Other(a)
1,006.3

 
874.6

Total Assets
$
2,195.9

 
$
2,071.8

_______________________________________________
(a)
Corporate and other assets includes corporate assets, certain current assets and liabilities associated with discontinued operations that we will retain after closing the Divestiture and assets held for sale.